Year-end report 1 January - 31 December 2023
Strong cash flow and significant actions to improve profitability within Medtech Demand is healthy in the markets and segments where AddLife's companies operate. We can now summarize 2023 as a year...
Stay updated with breaking news from Fredrik Dalborg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strong cash flow and significant actions to improve profitability within Medtech Demand is healthy in the markets and segments where AddLife's companies operate. We can now summarize 2023 as a year...
The shareholders of AddLife AB , reg. no 556995-8126, are hereby given notice to attend the Annual General Meeting to be held at 4:00 p.m. CEST, Thursday, 4 May 2023, at World Trade Center, room New... | March 29, 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / January 27, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)Year ends on strong quarterFourth quarter 2021 (October 1 - December 31)• Net sales amounted to SEK
XVIVO Presents Report on Operations 2021 - read this article along with other careers information, tips and advice on BioSpace
GOTHENBURG, SWEDEN / ACCESSWIRE / December 08, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)To successfully execute on XVIVO's strategy, Fredrik Dalborg has been appointed Managing Director